MESOX has been prominently featured in the International Biopharmaceutical Industry journal. The article, titled “Are We Ready to Formulate the Next Generation of Small Targeted Therapeutics?”, highlights the company’s revolutionary MesoPAC carrier as a key solution for the unique challenges presented by emerging drug modalities like PROTACs.

The article emphasizes the growing importance of overcoming formulation challenges, such as poor solubility and bioavailability, faced by these novel therapeutics. MESOX’s MesoPAC carrier, engineered from an FDA-approved cellulose derivative, offers a groundbreaking approach to enhance drug dissolution and stability, paving the way for greater therapeutic effectiveness.

The publication details the carrier’s success in formulating complex molecules, including PROTACs, and underscores its potential to accelerate the development of targeted therapies, ultimately leading to improved patient outcomes. This recognition in a leading industry journal solidifies MESOX’s position in drug delivery and showcases the transformative potential of its nanopore carrier technology. For references, the written publication by MESOX is featured on pages 22-23 of Volume 6, Issue 2 of the IBI Journal.

MESOX’s Mesoporous Carrier Technology Featured in International Biopharmaceutical Industry Journal

By |2024-07-13T20:43:34+00:00July 10th, 2023|

MESOX has been prominently featured in the International Biopharmaceutical Industry journal. The article, titled "Are We Ready to Formulate the Next Generation of Small Targeted Therapeutics?", highlights the company's revolutionary MesoPAC carrier as a key solution for the unique challenges presented by emerging drug modalities like PROTACs. The article emphasizes the growing importance of overcoming [...]

Read More

Another achievement for MESOX!

By |2023-05-17T23:58:52+00:00June 18th, 2022|

Your Content Goes Here We're a Finalist! In June 2022, we learnt that MESOX was shortlisted as a Finalist at the RSC’s Emerging Technologies Competition under its Health Category. This is the 10th year for this competition and we are delighted to receive the news at this important time in [...]

Read More

Participation at LSX World Congress 2022

By |2022-08-03T10:23:37+00:00June 30th, 2017|

Your Content Goes Here In May 2022, MESOX participated in the activities of the LSX World Congress in London. The meeting brought together executives and leaders from Biotech, Healthtech and Medtech companies to discuss the latest developments in life sciences and partnership opportunities. At the event, our team had the opportunity to [...]

Read More

© Copyright - 2024 | All Rights Reserved

Go to Top